{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": true,
    "complex_factors": [
        "Synthetic replication via unfunded swaps",
        "Use of FX forward contracts",
        "Counterparty risk due to swap counterparties",
        "Inverse exposure to CNY relative to USD",
        "Collateralised debt security structure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Short CNY Long USD product is an Exchange Traded Product (ETP) structured as a collateralised debt security that provides inverse exposure to the Chinese Renminbi (CNY) relative to the US Dollar (USD). It tracks the MSFXSM Short Chinese Renminbi Total Return Index, which is based on the daily performance of FX forward contracts (derivatives) that are short CNY vs USD. The replication method is explicitly synthetic, using unfunded swap agreements with collateral held at The Bank of New York Mellon. The product exposes investors to counterparty risk from swap counterparties, mitigated by daily marked-to-market collateral. The product is not UCITS compliant. The risk profile is low (2/7), but the product is described as 'not simple and may be difficult to understand' and intended for investors with specific knowledge or experience. The use of swaps and derivatives is inherent to the investment strategy, not merely for risk management. The product provides inverse exposure (short CNY), which is a complexity trigger. There is no leverage above 1:1, but the inverse nature and synthetic replication via swaps classify it as complex under MiFID II. The PRIIPs KID and factsheet confirm the synthetic unfunded swap structure, counterparty risk, and collateral arrangements. No capital protection or structured contingent features are present. Costs include management fees and transaction costs but no performance fees. Overall, the key complexity drivers are the synthetic replication via unfunded swaps, counterparty risk, and inverse exposure to FX forwards, making the product complex under MiFID II."
}